We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTate & Lyle Regulatory News (TATE)

Share Price Information for Tate & Lyle (TATE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 634.00
Bid: 632.00
Ask: 633.00
Change: 0.00 (0.00%)
Spread: 1.00 (0.158%)
Open: 642.50
High: 642.50
Low: 630.00
Prev. Close: 634.00
TATE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

8 Nov 2023 07:00

RNS Number : 7057S
Tate & Lyle PLC
08 November 2023
 

Directorate Change

 

Tate & Lyle PLC (Tate & Lyle) is pleased to announce the appointment of David Hearn as a Director and Chair of the Board of Tate & Lyle from 1 January 2024. On appointment, he will also become Chair of the Nominations Committee.

 

David Hearn is a highly experienced Chair both of listed companies and privately owned businesses.  He currently serves as Chair of Safestore Holdings plc and is also Chair of The a2 Milk Company, a company listed on the New Zealand and Australian Stock Exchanges, a position he will step down from on 16 November 2023.  He is a non-executive director of Lovat Partners Ltd. 

 

In a career spanning more than 40 years, David has held senior roles in a number of global businesses, including in the food and beverage industry with Del Monte, PepsiCo and United Biscuits. David served as Chief Executive Officer (CEO) of Goodman Fielder, a listed Australian food business, from 1995 to 2001 and also as CEO of Cordiant Group plc in the US from 2001 to 2003. In 2005, he was appointed CEO of Committed Capital, an international private equity and advisory firm based in London and Sydney, for whom he acted as Chair of a wide range of portfolio businesses over a twelve-year period.

 

David Hearn will succeed Warren Tucker who has been Interim Chair since 1 September 2023. Warren will continue to serve as a Non-Executive Director and Chair of the Audit Committee after he steps down as Interim Chair.

 

Paul Forman, Senior Independent Director, who led the search for the new Chair, will retire from the Board on 31 December 2023 and, as previously announced, Kim Nelson will take up the position of Senior Independent Director of Tate & Lyle from 1 January 2024.

 

Commenting on David's appointment, Warren Tucker, Interim Chair, said:

"The Board is delighted that David Hearn will be joining Tate & Lyle as Chair in January. David's breadth of experience, skills and knowledge, particularly of the food industry, will complement and further strengthen Tate & Lyle's Board. I look forward to working closely with him to ensure a smooth handover during the coming weeks."

 

David Hearn said:

"I am delighted to take on the role of Chair of Tate & Lyle at what is an exciting time for the business. Tate & Lyle is a business with a deep sense of purpose, in a strong financial position, which puts its customers at the heart of everything it does. I look forward to working with the Board, Nick Hampton and the leadership team to deliver on the Company's growth agenda."

Nick Hampton, Chief Executive, said:

"We look forward to welcoming David to Tate & Lyle and to working with him to deliver on our strategy to create solutions that meet growing consumer demand for healthier, tastier and more sustainable food and drink. On behalf of the Board, I would like to thank Warren Tucker for his diligent leadership of the Board during this interim period, and also to thank Paul Forman for his leadership of the Chair succession process, his service as the Senior Independent Director, and for his significant contribution to the Tate & Lyle Board over the last nine years."

 

There are no further details to be disclosed pursuant to Listing Rule 9.6.13 in connection with Mr Hearn's appointment. Biographical details for Mr Hearn are set out below.

 

For more information contact Tate & Lyle PLC:

Christopher Marsh, VP Investor Relations

Tel: Mobile: +44 (0) 7796 192 688

 

Nick Hasell, FTI Consulting (Media)

Tel: Mobile: +44 (0) 7825 523 383

 

 

About Mr David Hearn

 

David Hearn is the Chair of Safestore Holdings plc and a non-executive director of Lovat Partners Ltd. 

 

David became a non-executive director and deputy Chair of The a2 Milk Company in 2014 becoming the Chair in 2018. David will serve as the Chair of The a2 Milk Company, a company listed on the New Zealand Stock Exchange and dual listed on the Australian Stock Exchange, until 16 November 2023 when he will step down from the board.

 

Between 2005 and 2018, David held non-executive directorships on the boards of LifeCare Residences Ltd, Committed Capital PE, and Comqi Holdings Ltd, and he was Chair of Hammonds LLP.

 

David started his career in 1977 with Procter & Gamble before joining the food industry in 1984 as the CEO for Del Monte's business in the UK and Ireland. After the business was acquired by Nabisco, David was given responsibility for leading the Smiths Crisps division which he did for three years until, in 1990, Nabisco was acquired by PepsiCo. David was appointed into a divisional VP role with responsibility for running the Snackfoods division in Europe based in Barcelona. In 1992, David joined United Biscuits as deputy CEO running the snacks business worldwide, which included KP Snacks, Ross Youngs and McVitie's. After a successful three years of acquisitions and growth, David accepted the role of CEO of Goodman Fielder, the listed Australian business and he relocated to Sydney in 1995. In 2001, David moved to the US to become the CEO of Cordiant Group plc, based in New York. When that business was acquired by WPP in 2003/2004 David returned to Europe. In 2005, David was appointed CEO of Committed Capital, an international private equity and advisory firm with offices in London and Sydney. Over the next twelve years, David operated as Chair for a range of portfolio businesses, spanning travel, technology, media, legal and B2B.

 

Mr Hearn received an MA in English Literature from Oxford University.

 

About Tate & Lyle: Supported by our 160-year history of ingredient innovation, we partner with customers to provide consumers with healthier and tastier choices when they eat and drink. We are proud that millions of people around the world consume products containing our ingredients every day.

Through our expertise in sweetening, fortification, and mouthfeel, we develop ingredient solutions which reduce sugar, calories, and fat, add fibre and protein, and provide texture and stability in categories including beverage, dairy, bakery and snacks, and soups, sauces, and dressings.

We have more than 3,600 employees working in 58 locations across the world. Science, Solutions, Society is our brand promise and how we will achieve our purpose of Transforming Lives Through the Science of Food. By living our purpose we believe we can successfully grow our business and have a positive impact on society. We live our purpose in three ways, by supporting healthy living, building thriving communities and caring for our planet.

Tate & Lyle is listed on the London Stock Exchange under the symbol TATE.L. American Depositary Receipts trade under TATYY. In the year to 31 March 2023, Tate & Lyle revenue totalled £1.75 billion. For more information, please visit https://www.tateandlyle.com or follow Tate & Lyle on Twitter, Linkedin, Facebook or YouTube.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAFSFFAWEDSEIF
Date   Source Headline
25th Apr 20243:45 pmRNSHolding(s) in Company
24th Apr 20247:00 amRNSDirectorate Change
22nd Apr 20242:30 pmRNSDirector/PDMR Shareholding
19th Apr 202410:15 amRNSHolding(s) in Company
17th Apr 20244:15 pmRNSHolding(s) in Company
17th Apr 202410:30 amRNSHolding(s) in Company
15th Apr 202410:30 amRNSHolding(s) in Company
10th Apr 20243:45 pmRNSHolding(s) in Company
8th Apr 202411:15 amRNSHolding(s) in Company
5th Apr 20243:45 pmRNSHolding(s) in Company
4th Apr 20244:15 pmRNSHolding(s) in Company
4th Apr 202412:30 pmRNSHolding(s) in Company
4th Apr 202411:30 amRNSDirector/PDMR Shareholding
2nd Apr 202412:45 pmRNSTotal Voting Rights
2nd Apr 202411:30 amRNSHolding(s) in Company
28th Mar 202411:45 amRNSHolding(s) in Company
25th Mar 202411:45 amRNSHolding(s) in Company
21st Mar 20244:10 pmRNSHolding(s) in Company
20th Mar 20243:00 pmRNSHolding(s) in Company
20th Mar 202412:00 pmRNSHolding(s) in Company
19th Mar 20242:00 pmRNSHolding(s) in Company
13th Mar 20244:00 pmRNSHolding(s) in Company
12th Mar 20244:24 pmRNSHolding(s) in Company
12th Mar 20244:22 pmRNSHolding(s) in Company
7th Mar 20247:00 amRNSDirectorate Change
4th Mar 20242:00 pmRNSDirector/PDMR Shareholding
4th Mar 20241:45 pmRNSHolding(s) in Company
28th Feb 20242:30 pmRNSHolding(s) in Company
21st Feb 20247:00 amRNSTrading Statement
1st Feb 202412:00 pmRNSTotal Voting Rights
11th Jan 20241:00 pmRNSDirector/PDMR Shareholding
2nd Jan 202412:00 pmRNSBlock listing Interim Review
8th Dec 202311:45 amRNSDirector/PDMR Shareholding
6th Dec 202310:30 amRNSHolding(s) in Company
27th Nov 20234:15 pmRNSHolding(s) in Company
23rd Nov 20232:30 pmRNSHolding(s) in Company
20th Nov 202310:00 amRNSHolding(s) in Company
9th Nov 20237:00 amRNSHalf-year Report
8th Nov 20237:00 amRNSDirectorate Change
23rd Oct 202310:30 amRNSHolding(s) in Company
16th Oct 202310:30 amRNSHolding(s) in Company
13th Oct 202310:30 amRNSHolding(s) in Company
12th Oct 202311:00 amRNSHolding(s) in Company
2nd Oct 202310:23 amRNSDirector Declaration
1st Sep 202311:00 amRNSTotal Voting Rights
25th Aug 20233:45 pmRNSHolding(s) in Company
17th Aug 20234:30 pmRNSHolding(s) in Company
15th Aug 20234:30 pmRNSHolding(s) in Company
10th Aug 20234:00 pmRNSHolding(s) in Company
7th Aug 202312:15 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.